These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 14582073

  • 1. Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Tang S, Tang AW, Tam MK, Ho YW.
    Am J Kidney Dis; 2003 Nov; 42(5):E13-5. PubMed ID: 14582073
    [Abstract] [Full Text] [Related]

  • 2. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 3. Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome.
    Westhoff TH, Schmidt S, Zidek W, Beige J, van der Giet M.
    Clin Nephrol; 2006 Jun; 65(6):393-400. PubMed ID: 16792133
    [Abstract] [Full Text] [Related]

  • 4. Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome.
    Schweda F, Liebl R, Riegger GA, Krämer BK.
    Nephrol Dial Transplant; 1997 Nov; 12(11):2433-5. PubMed ID: 9394341
    [No Abstract] [Full Text] [Related]

  • 5. Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with De Novo Minimal Change Disease: A Multicenter, Randomized, Controlled Trial.
    Medjeral-Thomas NR, Lawrence C, Condon M, Sood B, Warwicker P, Brown H, Pattison J, Bhandari S, Barratt J, Turner N, Cook HT, Levy JB, Lightstone L, Pusey C, Galliford J, Cairns TD, Griffith M.
    Clin J Am Soc Nephrol; 2020 Feb 07; 15(2):209-218. PubMed ID: 31953303
    [Abstract] [Full Text] [Related]

  • 6. [Minimal Change Glomerulonephritis].
    Stracke S, Helmchen U, Aymanns C, Kadlec N, Lindemann B, Hüttner S, Keller F.
    Internist (Berl); 2003 Sep 07; 44(9):1090-7. PubMed ID: 14566462
    [Abstract] [Full Text] [Related]

  • 7. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
    Kidney Int; 2012 Nov 07; 82(10):1130-5. PubMed ID: 22763815
    [Abstract] [Full Text] [Related]

  • 8. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ, Deegens JK, Beukhof JR, Reichert LJ, Ten Dam MA, Beutler JJ, van den Wall Bake AWL, Rensma PL, Konings CJ, Geerse DA, Feith GW, Van Kuijk WH, Wetzels JF.
    Am J Kidney Dis; 2017 May 07; 69(5):637-646. PubMed ID: 28089478
    [Abstract] [Full Text] [Related]

  • 9. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
    Li H, Shi X, Shen H, Li X, Wang H, Li H, Xu G, Chen J.
    Clin Ther; 2012 May 07; 34(5):1112-20. PubMed ID: 22503105
    [Abstract] [Full Text] [Related]

  • 10. Tacrolimus improves proteinuria remission in adults with cyclosporine A-resistant or -dependent minimal change disease.
    Xu D, Gao X, Bian R, Mei C, Xu C.
    Nephrology (Carlton); 2017 Mar 07; 22(3):251-256. PubMed ID: 28035723
    [Abstract] [Full Text] [Related]

  • 11. Chronic nephrotoxicity limits successful use of Tacrolimus in the management of adult steroid-dependent minimal change disease.
    Ramachandran R, Kumar D A P, Nada R, Jha V, Gupta KL, Kohli HS.
    Nephrology (Carlton); 2015 May 07; 20(5):384-5. PubMed ID: 25872662
    [No Abstract] [Full Text] [Related]

  • 12. Combined cyclosporine and prednisolone therapy using cyclosporine blood concentration monitoring for adult patients with new-onset minimal change nephrotic syndrome: a single-center pilot randomized trial.
    Shirai S, Imai N, Sueki S, Matsui K, Tominaga N, Sakurada T, Yasuda T, Kimura K, Shibagaki Y.
    Clin Exp Nephrol; 2018 Apr 07; 22(2):283-290. PubMed ID: 28699032
    [Abstract] [Full Text] [Related]

  • 13. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Ueda N, Takahashi K, Akioka Y, Morooka M, Ogawa A, Tsuzuki K.
    J Nephrol; 2009 Apr 07; 22(5):610-5. PubMed ID: 19809993
    [Abstract] [Full Text] [Related]

  • 14. Tacrolimus as the first-line agent in adult-onset minimal change disease: A randomized controlled study.
    Patil MR, Divyaveer SS, Raychaudhary A, Trivedi M, Mahajan C, Sarkar D, Pandey R.
    Saudi J Kidney Dis Transpl; 2019 Apr 07; 30(1):129-137. PubMed ID: 30804274
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the Efficacy and Safety of Tacrolimus and Low-Dose Corticosteroid with High-Dose Corticosteroid for Minimal Change Nephrotic Syndrome in Adults.
    Chin HJ, Chae DW, Kim YC, An WS, Ihm C, Jin DC, Kim SG, Kim YL, Kim YS, Kim YG, Koo HS, Lee JE, Lee KW, Oh J, Park JH, Jiang H, Lee H, Lee SK.
    J Am Soc Nephrol; 2021 Jan 07; 32(1):199-210. PubMed ID: 33168602
    [Abstract] [Full Text] [Related]

  • 16. [Complete remission of steroid-resistant minimal-change nephrotic syndrome by cyclosporin after additional low-density lipoprotein apheresis treatment].
    Okada T, Takahashi H, Ogura M, Nakao T, Shimizu T.
    Nihon Jinzo Gakkai Shi; 1996 Jan 07; 38(1):46-51. PubMed ID: 8855137
    [Abstract] [Full Text] [Related]

  • 17. The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome.
    Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H.
    Am J Nephrol; 2000 Jan 07; 20(3):175-9. PubMed ID: 10878397
    [Abstract] [Full Text] [Related]

  • 18. Successful treatment of steroid-resistant minimal change disease with mycophenolate mofetil.
    Mogyorósi A, Lippman HR, Feldman GM.
    Am J Nephrol; 2002 Jan 07; 22(5-6):569-72. PubMed ID: 12381961
    [Abstract] [Full Text] [Related]

  • 19. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
    Li X, Li H, Chen J, He Q, Lv R, Lin W, Li Q, He X, Qu L, Suya W.
    Nephrol Dial Transplant; 2008 Jun 07; 23(6):1919-25. PubMed ID: 17911091
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus as rescue therapy for adult-onset refractory minimal change nephrotic syndrome with reversible acute renal failure.
    Li X, Xu N, Li H, Han F, Wang R, He Q, He X, Chen J.
    Nephrol Dial Transplant; 2013 Sep 07; 28(9):2306-12. PubMed ID: 23787554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.